ANXA11 | OmnibusX

I. Expression across cell types

Name	Number of supported studies	Average coverage
natural killer cell	34 studies	34% ± 12%	Explore
macrophage	33 studies	31% ± 12%	Explore
CD8-positive, alpha-beta T cell	31 studies	36% ± 14%	Explore
endothelial cell	30 studies	26% ± 10%	Explore
B cell	29 studies	28% ± 11%	Explore
T cell	29 studies	31% ± 12%	Explore
fibroblast	29 studies	28% ± 13%	Explore
CD4-positive, alpha-beta T cell	29 studies	36% ± 12%	Explore
pericyte	26 studies	25% ± 7%	Explore
mast cell	24 studies	38% ± 13%	Explore
smooth muscle cell	24 studies	27% ± 11%	Explore
regulatory T cell	24 studies	42% ± 16%	Explore
classical monocyte	23 studies	34% ± 12%	Explore
conventional dendritic cell	22 studies	34% ± 13%	Explore
epithelial cell	22 studies	47% ± 21%	Explore
monocyte	20 studies	31% ± 10%	Explore
non-classical monocyte	20 studies	36% ± 13%	Explore
mature NK T cell	19 studies	31% ± 11%	Explore
plasmacytoid dendritic cell	19 studies	40% ± 14%	Explore
dendritic cell	18 studies	37% ± 17%	Explore
memory B cell	18 studies	29% ± 8%	Explore
basal cell	18 studies	42% ± 15%	Explore
ciliated cell	18 studies	57% ± 16%	Explore
naive B cell	17 studies	26% ± 8%	Explore
gamma-delta T cell	17 studies	36% ± 13%	Explore
naive thymus-derived CD4-positive, alpha-beta T cell	15 studies	30% ± 11%	Explore
CD16-negative, CD56-bright natural killer cell, human	14 studies	31% ± 11%	Explore
CD16-positive, CD56-dim natural killer cell, human	14 studies	38% ± 13%	Explore
myeloid cell	14 studies	34% ± 11%	Explore
naive thymus-derived CD8-positive, alpha-beta T cell	13 studies	37% ± 12%	Explore
CD8-positive, alpha-beta memory T cell	12 studies	39% ± 15%	Explore
type I pneumocyte	11 studies	45% ± 13%	Explore
CD4-positive, alpha-beta memory T cell	11 studies	39% ± 15%	Explore
club cell	11 studies	43% ± 17%	Explore
secretory cell	11 studies	51% ± 12%	Explore
plasma cell	10 studies	29% ± 9%	Explore
effector memory CD8-positive, alpha-beta T cell	10 studies	31% ± 14%	Explore
capillary endothelial cell	10 studies	22% ± 3%	Explore
myofibroblast cell	10 studies	30% ± 10%	Explore
mucosal invariant T cell	10 studies	34% ± 10%	Explore
type II pneumocyte	9 studies	29% ± 10%	Explore
mesothelial cell	9 studies	35% ± 18%	Explore
vein endothelial cell	9 studies	22% ± 7%	Explore
alveolar macrophage	8 studies	42% ± 15%	Explore
plasmablast	8 studies	35% ± 21%	Explore
endothelial cell of artery	8 studies	20% ± 3%	Explore
respiratory goblet cell	7 studies	59% ± 17%	Explore
leukocyte	7 studies	24% ± 6%	Explore
enterocyte	7 studies	31% ± 10%	Explore
goblet cell	7 studies	41% ± 12%	Explore
abnormal cell	7 studies	30% ± 16%	Explore
connective tissue cell	7 studies	30% ± 10%	Explore
progenitor cell	7 studies	28% ± 9%	Explore
T follicular helper cell	7 studies	32% ± 9%	Explore
endothelial cell of vascular tree	7 studies	27% ± 5%	Explore
endothelial cell of lymphatic vessel	6 studies	21% ± 5%	Explore
hematopoietic precursor cell	6 studies	35% ± 13%	Explore
neutrophil	6 studies	30% ± 12%	Explore
mononuclear phagocyte	6 studies	31% ± 11%	Explore
kidney loop of Henle epithelial cell	6 studies	45% ± 16%	Explore
kidney distal convoluted tubule epithelial cell	6 studies	38% ± 22%	Explore
innate lymphoid cell	6 studies	31% ± 10%	Explore
adipocyte	6 studies	18% ± 2%	Explore
effector memory CD4-positive, alpha-beta T cell	6 studies	44% ± 21%	Explore
effector memory CD8-positive, alpha-beta T cell, terminally differentiated	5 studies	26% ± 9%	Explore
exhausted T cell	5 studies	49% ± 11%	Explore
platelet	5 studies	22% ± 2%	Explore
effector CD8-positive, alpha-beta T cell	5 studies	39% ± 13%	Explore
renal alpha-intercalated cell	5 studies	48% ± 4%	Explore
transit amplifying cell	5 studies	28% ± 16%	Explore
precursor B cell	5 studies	31% ± 6%	Explore
microglial cell	5 studies	25% ± 7%	Explore
adventitial cell	5 studies	28% ± 10%	Explore
cardiac muscle cell	5 studies	23% ± 2%	Explore
effector CD4-positive, alpha-beta T cell	5 studies	46% ± 25%	Explore
CD4-positive helper T cell	4 studies	24% ± 7%	Explore
deuterosomal cell	4 studies	40% ± 10%	Explore
ionocyte	4 studies	25% ± 4%	Explore
squamous epithelial cell	4 studies	74% ± 10%	Explore
pancreatic A cell	4 studies	43% ± 19%	Explore
hematopoietic stem cell	4 studies	26% ± 4%	Explore
lymphocyte	4 studies	36% ± 12%	Explore
megakaryocyte	4 studies	26% ± 5%	Explore
pro-B cell	4 studies	25% ± 7%	Explore
intermediate monocyte	4 studies	44% ± 21%	Explore
granulocyte	4 studies	38% ± 15%	Explore
glutamatergic neuron	4 studies	36% ± 17%	Explore
brush cell	4 studies	33% ± 6%	Explore
T-helper 17 cell	4 studies	34% ± 15%	Explore
central memory CD8-positive, alpha-beta T cell	3 studies	21% ± 4%	Explore
duct epithelial cell	3 studies	51% ± 14%	Explore
glomerular endothelial cell	3 studies	24% ± 3%	Explore
intestinal crypt stem cell	3 studies	25% ± 7%	Explore
common myeloid progenitor	3 studies	32% ± 17%	Explore
immature B cell	3 studies	39% ± 7%	Explore
tissue-resident macrophage	3 studies	28% ± 7%	Explore
intraepithelial lymphocyte	3 studies	35% ± 14%	Explore
germinal center B cell	3 studies	26% ± 2%	Explore
luminal hormone-sensing cell of mammary gland	3 studies	33% ± 7%	Explore
luminal cell of prostate epithelium	3 studies	32% ± 9%	Explore
muscle cell	3 studies	34% ± 18%	Explore
GABAergic neuron	3 studies	21% ± 3%	Explore
pancreatic ductal cell	3 studies	78% ± 10%	Explore
mucus secreting cell	3 studies	26% ± 8%	Explore
group 3 innate lymphoid cell	3 studies	30% ± 8%	Explore
T-helper 1 cell	3 studies	49% ± 13%	Explore
double negative thymocyte	3 studies	42% ± 15%	Explore
astrocyte	3 studies	17% ± 1%	Explore
erythrocyte	3 studies	24% ± 6%	Explore

II. Expression across tissues

Name	Number of supported studies	Average coverage
lung	18 studies	36% ± 12%	Explore
peripheral blood	18 studies	34% ± 12%	Explore
intestine	11 studies	22% ± 9%	Explore
kidney	6 studies	30% ± 8%	Explore
brain	5 studies	25% ± 11%	Explore
pancreas	4 studies	44% ± 17%	Explore
bone marrow	4 studies	26% ± 9%	Explore
uterus	4 studies	35% ± 15%	Explore
lymph node	4 studies	34% ± 8%	Explore
breast	4 studies	24% ± 5%	Explore
liver	4 studies	24% ± 3%	Explore
adipose	4 studies	22% ± 7%	Explore
placenta	3 studies	38% ± 14%	Explore
heart	3 studies	19% ± 1%	Explore
prostate	3 studies	34% ± 12%	Explore

Tissue	GTEx Coverage	GTEx Average TPM	GTEx Number of samples	TCGA Coverage	TCGA Average TPM	TCGA Number of samples
intestine	100%	14471.06	966 / 966	100%	130.51	527 / 527
ovary	100%	9454.86	180 / 180	100%	125.72	430 / 430
prostate	100%	12992.31	245 / 245	100%	116.79	502 / 502
stomach	100%	12725.40	359 / 359	100%	127.30	286 / 286
kidney	100%	16273.70	89 / 89	100%	101.78	900 / 901
uterus	100%	10579.85	170 / 170	100%	102.90	458 / 459
thymus	100%	9877.56	652 / 653	100%	81.27	604 / 605
lung	100%	14932.79	577 / 578	100%	102.47	1153 / 1155
bladder	100%	15031.81	21 / 21	100%	115.18	502 / 504
skin	100%	11258.44	1808 / 1809	100%	68.80	470 / 472
esophagus	100%	17816.27	1445 / 1445	99%	114.28	182 / 183
pancreas	99%	7529.45	326 / 328	100%	146.53	178 / 178
breast	100%	15765.62	459 / 459	99%	74.79	1110 / 1118
liver	77%	3081.84	174 / 226	99%	55.55	400 / 406
brain	82%	4737.62	2175 / 2642	79%	24.26	557 / 705
adrenal gland	92%	3879.67	237 / 258	35%	11.37	81 / 230
adipose	100%	17861.35	1204 / 1204	0%	0	0 / 0
blood vessel	100%	19596.06	1335 / 1335	0%	0	0 / 0
eye	0%	0	0 / 0	100%	112.02	80 / 80
lymph node	0%	0	0 / 0	100%	115.54	29 / 29
muscle	100%	14339.99	803 / 803	0%	0	0 / 0
spleen	100%	10665.11	241 / 241	0%	0	0 / 0
tonsil	0%	0	0 / 0	100%	85.38	45 / 45
ureter	0%	0	0 / 0	100%	89.63	1 / 1
peripheral blood	100%	22683.98	926 / 929	0%	0	0 / 0
heart	99%	18780.81	850 / 861	0%	0	0 / 0
abdomen	0%	0	0 / 0	0%	0	0 / 0
bone marrow	0%	0	0 / 0	0%	0	0 / 0
diaphragm	0%	0	0 / 0	0%	0	0 / 0
gingiva	0%	0	0 / 0	0%	0	0 / 0
nasal cavity	0%	0	0 / 0	0%	0	0 / 0
nasopharynx	0%	0	0 / 0	0%	0	0 / 0
nose	0%	0	0 / 0	0%	0	0 / 0
placenta	0%	0	0 / 0	0%	0	0 / 0
spinal column	0%	0	0 / 0	0%	0	0 / 0

III. Associated gene sets

GO_0032506	Biological process	cytokinetic process
GO_0006909	Biological process	phagocytosis
GO_0051592	Biological process	response to calcium ion
GO_0030496	Cellular component	midbody
GO_0005886	Cellular component	plasma membrane
GO_0012506	Cellular component	vesicle membrane
GO_0016020	Cellular component	membrane
GO_0070062	Cellular component	extracellular exosome
GO_0005654	Cellular component	nucleoplasm
GO_0062023	Cellular component	collagen-containing extracellular matrix
GO_0042581	Cellular component	specific granule
GO_0005635	Cellular component	nuclear envelope
GO_0042582	Cellular component	azurophil granule
GO_0005829	Cellular component	cytosol
GO_0045335	Cellular component	phagocytic vesicle
GO_0005737	Cellular component	cytoplasm
GO_0042470	Cellular component	melanosome
GO_0005819	Cellular component	spindle
GO_0005634	Cellular component	nucleus
GO_0005544	Molecular function	calcium-dependent phospholipid binding
GO_0001786	Molecular function	phosphatidylserine binding
GO_0048306	Molecular function	calcium-dependent protein binding
GO_0003723	Molecular function	RNA binding
GO_0023026	Molecular function	MHC class II protein complex binding
GO_0008429	Molecular function	phosphatidylethanolamine binding
GO_0044548	Molecular function	S100 protein binding
GO_0005509	Molecular function	calcium ion binding
GO_0005515	Molecular function	protein binding

IV. Literature review

[source]

Gene name	ANXA11
Protein name	Annexin A11 Annexin Annexin A11 (56 kDa autoantigen) (Annexin XI) (Annexin-11) (Calcyclin-associated annexin 50) (CAP-50)
Synonyms	hCG_22492 ANX11
Description	FUNCTION: Binds specifically to calcyclin in a calcium-dependent manner (By similarity). Required for midbody formation and completion of the terminal phase of cytokinesis. .
Accessions	ENST00000265447.8 [P50995-2] Q5T0G8 H0Y6E1 Q5T0G7 ENST00000422982.8 [P50995-1] P50995 Q6ICS0 ENST00000438331.5 [P50995-1] ENST00000372231.7 [P50995-1] ENST00000447489.1 ENST00000437799.1

ANXA11 report

I. Expression across cell types

II. Expression across tissues

III. Associated gene sets

IV. Literature review